Published in Int J Crit Illn Inj Sci on July 01, 2014
Kidney Injury Molecule-1 and Cardiovascular Diseases: From Basic Science to Clinical Practice. Biomed Res Int (2015) 0.75
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care (2007) 29.89
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther (2001) 14.78
Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet (2005) 13.77
Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol (2003) 9.08
Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J (2000) 8.43
Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int (2007) 6.61
Acute renal failure. Lancet (2005) 5.60
Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest (2005) 5.51
Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol (2007) 4.99
Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation (2000) 4.81
Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int (2007) 4.74
Early detection of acute renal failure by serum cystatin C. Kidney Int (2004) 4.62
Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients. Am J Respir Crit Care Med (2010) 4.61
Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int (2006) 3.96
Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol (2007) 3.48
Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol (2005) 3.38
Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis (2004) 3.35
Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care (2007) 3.29
Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int (2007) 3.23
The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat Med (2011) 3.20
Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest (2001) 2.84
Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol (2002) 2.83
Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol (2007) 2.63
Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure. J Am Coll Cardiol (2008) 2.36
Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med (2008) 2.32
Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int (2007) 2.22
Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction. Ann Med (2010) 2.21
Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation (2000) 2.18
Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transplant (2009) 2.12
Structure and expression of the human cystatin C gene. Biochem J (1990) 2.07
Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int (2009) 1.94
Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury. Biomark Med (2010) 1.90
Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients. Crit Care (2005) 1.88
B-type natriuretic peptide in paediatric patients with congenital heart disease. Eur Heart J (2006) 1.77
Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury. Crit Care Med (2010) 1.74
Cardiac biomarkers in acute myocardial infarction. Int J Cardiol (2012) 1.71
Biomarkers for the early detection of acute kidney injury. Pediatr Nephrol (2007) 1.69
Urinary interleukin-18 is an acute kidney injury biomarker in critically ill children. Nephrol Dial Transplant (2007) 1.55
Reference intervals for brain natriuretic peptide in healthy newborns and infants measured with an automated immunoassay platform. Clin Chem Lab Med (2010) 1.44
Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. J Am Coll Cardiol (2010) 1.43
Early prediction of urinary tract infection with urinary neutrophil gelatinase associated lipocalin. Pediatr Nephrol (2009) 1.42
Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications. Acta Physiol (Oxf) (2013) 1.26
Biomarkers of acute kidney injury in children: discovery, evaluation, and clinical application. Pediatr Nephrol (2010) 1.25
Cystatin C: a promising marker and predictor of impaired renal function. Ann Clin Lab Sci (2006) 1.17
Emerging urinary biomarkers in the diagnosis of acute kidney injury. Expert Opin Med Diagn (2008) 1.15
Urinary fatty acid binding protein in renal disease. Clin Chim Acta (2006) 1.12
Plasmatic cystatin C for the estimation of glomerular filtration rate in intensive care units. Intensive Care Med (2004) 1.11
B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction. Circulation (2006) 1.11
Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury--where do we stand today? Nephrol Dial Transplant (2011) 1.10
Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy. Am J Kidney Dis (2006) 1.10
Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants. Pediatrics (2005) 1.10
Serum and urinary neutrophil gelatinase-associated lipocalin levels in children with chronic renal diseases. Pediatr Int (2010) 1.07
Evaluation of renal function in intensive care: plasma cystatin C vs. creatinine and derived glomerular filtration rate estimates. Clin Chem Lab Med (2005) 1.05
Urine biochemistry in septic and non-septic acute kidney injury: a prospective observational study. J Crit Care (2012) 1.04
Clinical value of NT-ProBNP and BNP in pediatric cardiology. J Card Fail (2005) 1.03
B-type natriuretic peptide levels predict outcome after neonatal cardiac surgery. J Thorac Cardiovasc Surg (2007) 1.00
Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics (2002) 0.98
Amino-terminal pro-brain-type natriuretic peptide: heart or lung disease in pediatric respiratory distress? Pediatrics (2005) 0.95
Liver-type fatty acid-binding protein attenuates renal injury induced by unilateral ureteral obstruction. Am J Pathol (2006) 0.95
High-sensitivity C-reactive protein is a good marker of cardiovascular risk in obese children and adolescents. Eur J Endocrinol (2008) 0.94
Impact of severe sepsis on serum and urinary biomarkers of acute kidney injury in critically ill children: an observational study. Blood Purif (2013) 0.93
Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress. Pediatr Cardiol (2004) 0.92
Plasma concentrations of NT-pro-BNP and cardiac troponin-I in relation to doxorubicin-induced cardiomyopathy and cardiac function in childhood malignancy. Saudi Med J (2005) 0.92
Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates. J Perinatol (2005) 0.91
Comparison of urinary neutrophil glucosaminidase-associated lipocalin, cystatin C, and α1-microglobulin for early detection of acute renal injury after cardiac surgery. Eur J Cardiothorac Surg (2010) 0.89
Diagnostic, prognostic and therapeutic relevance of B-type natriuretic hormone and related peptides in children with congenital heart diseases. Clin Chem Lab Med (2011) 0.89
A novel urinary biomarker profile to identify acute kidney injury (AKI) in critically ill neonates: a pilot study. Pediatr Nephrol (2013) 0.88
Impact of cardiac surgery on plasma levels of B-type natriuretic peptide in children with congenital heart disease. Int J Cardiol (2006) 0.88
Early detection of acute kidney injury by serum cystatin C in critically ill children. Pediatr Nephrol (2013) 0.87
Correlation of plasma N-terminal pro-brain natriuretic peptide levels with left ventricle mass in children treated with anthracyclines. Int J Cardiol (2005) 0.87
Concentrations of brain natriuretic peptide in the plasma predicts outcomes of treatment of children with decompensated heart failure admitted to the Intensive Care unit. Cardiol Young (2007) 0.86
Natriuretic peptides and heart disease in infants and children. J Pediatr (2005) 0.84
The clinical utility of urinary neutrophil gelatinase-associated lipocalin in the neonatal ICU. Curr Opin Pediatr (2010) 0.84
Troponins in children and neonates. Acta Paediatr (2003) 0.84
Clinical implications of serial serum N-terminal prohormone brain natriuretic peptide levels in the prediction of outcome in children with dilated cardiomyopathy. Am J Cardiol (2013) 0.83
Clinical application neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 as indicators of inflammation persistence and acute kidney injury in children with urinary tract infection. Biomed Res Int (2013) 0.82
Use of troponin as a screen for chest pain in the pediatric emergency department. Pediatr Cardiol (2011) 0.82
B-type natriuretic peptide as a marker for cardiac dysfunction in anthracycline-treated children. Pediatr Blood Cancer (2007) 0.82
Diagnostic accuracy of B-type natriuretic hormone for congenital heart disease in the first month of life. Clin Chem Lab Med (2010) 0.80
Myocardial dysfunction in pediatric septic shock. J Pediatr (2013) 0.79
Early prediction of anthracycline induced cardiotoxicity. Acta Paediatr (2007) 0.79
Hypertensive nephropathy in children - do we diagnose early enough? Blood Press (2012) 0.79
Diagnostic accuracy and clinical relevance of brain natriuretic peptide assay in pediatric patients with congenital heart diseases. J Cardiovasc Med (Hagerstown) (2009) 0.79
Neutrophil gelatinase-associated lipocalin as a follow-up marker in critically ill pediatric patients with established acute kidney injury. Ren Fail (2013) 0.77
Role of the NT-proBNP level in the diagnosis of pediatric heart failure and investigation of novel combined diagnostic criteria. Exp Ther Med (2013) 0.76
Serum troponin-I as an indicator of clinically significant myocardial injury in paediatric trauma patients. Injury (2011) 0.76
Cardiac troponin T as a screening test for myocarditis in children. Pediatr Emerg Care (2012) 0.76
Cardiac troponin I in congenital heart defects with pressure or volume overload. Scand Cardiovasc J (2012) 0.76
B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress. Acta Anaesthesiol Scand (2006) 0.75